您当前的位置：

JNJ0966

目录号: PL07414 纯度: ≥99%

JNJ0966 是一种高选择性 MMP-9 酶原抑制剂，其 IC50 值为 440 nM。

CAS No. :315705-75-0

商品编号	规格	价格	会员价
PL07414-5mg	5mg	¥2410.00	请登录
PL07414-10mg	10mg	¥3857.00	请登录
PL07414-25mg	25mg	¥8679.00	请登录
PL07414-50mg	50mg	¥15590.00	请登录
PL07414-100mg	100mg	询价	询价
PL07414-10mM*1mLinDMSO	10mM*1mLinDMSO	¥1911.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

*注意事项:下单时请联系销售核实产品价格及货期，避免后续产生不便，感谢支持!

加入购物车在线咨询收藏产品大包装询价

中文名称	JNJ0966
英文名称	JNJ0966
英文别名	JNJ0966;N-(2-((2-methoxyphenyl)amino)-4'-methyl-[4,5'-bithiazol]-2'-yl)acetamide;Oprea1_109350;Oprea1_487426;BCP25926;JNJ 0966;s5696;N-[5-[2-(2-methoxyanilino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]acetamide;N-(2-(2-Methoxyphenylamino)-4'-methyl-4,5'-bithiazol-2'-yl)acetamide;N-[2-[(2-Me
Cas No.	315705-75-0
分子式	C₁₆H₁₆N₄O₂S₂
分子量	360.45
包装储存	Powder -20°C 3 years；4°C 2 years
详情描述	JNJ0966 是一种高选择性 MMP-9 酶原抑制剂，其 IC50 值为 440 nM。

产品详情	JNJ0966 是一种高选择性 MMP-9 酶原抑制剂，其 IC₅₀ 值为 440 nM。
生物活性	JNJ0966 is a highly selective MMP-9 zymogen inhibitor with an IC 50 of 440 nM.
性状	Solid
IC50 & Target[1][2]	IC50: 440 nM (MMP-9 zymogen)
体外研究(In Vitro)	JNJ0966 is a highly selective MMP-9 zymogen inhibitor with an IC50 of 440 nM. The activations of proMMP-1, proMMP-2, and proMMP-3 are not significantly different in the presence or absence of 10 μM JNJ0966, whereas proMMP-9 activation by trypsin is significantly attenuated by JNJ0966. The addition of JNJ0966 to the reaction results in a significant reduction in fully processed MMP-9 and an apparent accumulation of the intermediate species. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)	The exposures of JNJ0966 are dose-dependent, with plasma and brain concentrations for the 10-mg/kg dose of 77.5±31.1 ng/mL (215 nM) and 481.6±162.5 ng/g (~1336 nM), respectively, whereas the 30-mg/kg dose achieves 293.6±118.4 ng/mL (815 nM) in plasma and 1394.0±649.1 ng/g (~3867 nM) in brain. JNJ0966 is preferentially partitioned in brain, with brain/plasma ratios of 6.2 for the 10-mg/kg dose and 4.7 for the 30-mg/kg dose. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Powder -20°C 3 years；4°C 2 years
参考文献	[1]. Scannevin RH, et al. Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) thatallosterically inhibits zymogen activation. J Biol Chem. 2017 Oct 27;292(43):17963-17974.

溶解度数据	In Vitro: DMSO : 100 mg/mL (277.43 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

JNJ0966

相关产品

The molarity calculator equation

The dilution calculator equation